Podcast

As long as Big Pharma wants it, and if there's a profit to be made, apparently our government will be there to provide lots of taxpayer funding. Actual healthcare is apparently a secondary concern. 

The Fed’s apparent plan to somehow get to full employment and then deal with inflation sounds nice, but reality could easily derail the plan. Meanwhile, job growth is low and prices are rising.

What we’re beginning to see is policy ghettoization, wherein states pass laws that the most fervent activists on the left and right, respectively, cannot enact at the federal level.

Paul Krugman’s “logical problem” with ABCT derives entirely from his superficial understanding of the theory.

The Fed is backed into a corner. If price inflation continues, the public could demand action and the Fed could be forced to cut back the flow of easy money, which may lead to a depression.

Bob reviews Mark Spitznagel's latest book, Safe Haven: Investing for Financial Storms, on which he was a consultant.

Calculating "multiplier effects" is perhaps the most common method of cheating with benefit-cost analysis.

The people who really run California aren't going anywhere. Even if California voters throw out Newsom very little will change in state government.

A patient, an electrophysiologist. and an Associate Professor of Radiology join Accad and Koka to discuss implantable defibrillators.

Some slippery slope arguments are a case of bad reasoning, but those presented by Mises and Hayek are not among them.